Paradromics has raised over $105 million in venture funding and secured $18 million in grants from the National Institutes of Health and DARPA, indicating strong confidence in its technology.
Founders
Matt Angle
Company Description
Paradromics is a neurotechnology company that has developed the Connexus brain-computer interface (BCI), which aims to restore communication for individuals with severe motor impairments by decoding brain signals and translating them into digital commands.